Quantbot Technologies LP Invests $84,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

Quantbot Technologies LP purchased a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 210 shares of the biotechnology company’s stock, valued at approximately $84,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. D.A. Davidson & CO. boosted its stake in shares of Axon Enterprise by 0.3% in the third quarter. D.A. Davidson & CO. now owns 12,622 shares of the biotechnology company’s stock worth $5,044,000 after buying an additional 44 shares during the last quarter. Dai ichi Life Insurance Company Ltd boosted its position in Axon Enterprise by 63.6% in the 3rd quarter. Dai ichi Life Insurance Company Ltd now owns 3,646 shares of the biotechnology company’s stock worth $1,457,000 after purchasing an additional 1,418 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in shares of Axon Enterprise by 0.6% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 43,643 shares of the biotechnology company’s stock valued at $17,440,000 after purchasing an additional 276 shares in the last quarter. DRW Securities LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $291,000. Finally, Harvest Fund Management Co. Ltd boosted its holdings in Axon Enterprise by 3,792.2% during the third quarter. Harvest Fund Management Co. Ltd now owns 1,985 shares of the biotechnology company’s stock worth $793,000 after buying an additional 1,934 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have weighed in on AXON. Needham & Company LLC lifted their price objective on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and raised their price objective for the company from $500.00 to $700.00 in a report on Tuesday. Robert W. Baird upped their target price on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $488.67.

Axon Enterprise Trading Down 0.3 %

AXON opened at $687.69 on Friday. The firm has a market capitalization of $52.44 billion, a price-to-earnings ratio of 177.70, a price-to-earnings-growth ratio of 14.74 and a beta of 1.01. The company’s 50 day simple moving average is $516.24 and its two-hundred day simple moving average is $392.27. Axon Enterprise, Inc. has a 1-year low of $232.78 and a 1-year high of $698.67. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 47,314 shares of the firm’s stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $400.07, for a total value of $18,928,911.98. Following the completion of the sale, the chief executive officer now directly owns 2,983,802 shares of the company’s stock, valued at $1,193,729,666.14. This trade represents a 1.56 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Julie A. Cullivan sold 1,261 shares of the business’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the transaction, the director now directly owns 2,392 shares in the company, valued at approximately $1,631,487.52. The trade was a 34.52 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 137,921 shares of company stock worth $63,093,907. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.